As Europe’s medical cannabis market matures, a new category of operator is beginning to emerge. One focused not simply on
Trump targets hemp products, DEA pushes medical cannabis operators toward Schedule III registration, a major lawsuit hits industry therapeutic claims, Curaleaf marks a UK manufacturing first, and Virginia’s adult-use sales bill awaits the governor’s signature.
Reform momentum builds on both sides of the Atlantic as Richard Branson presses for UK cannabis change, Indiana’s governor signals openness to legalisation, and analysts map the banking access unlocked by US rescheduling.
Today’s cannabis briefing covers the fallout from the US Justice Department’s Schedule III order, fresh travel guidance for UK medical patients, California’s ten-year legalisation milestone, environmental scrutiny at a Trulieve mega-grow, and a notable state-level legalisation recommendation in North Carolina.
This morning, the latest in a now-weekly series of stories in the British mainstream press was published in The Times,
The UK economic growth faces a paradox of two seemingly opposing pressures, yet both may be resolved by moving in
EXTINCTION EVENT? C4 Distribution shuts down after failing to raise money A memo signed by C4 CEO Eric Spitz says
THE Member of Parliament sponsoring the Medical Cannabis Access Bill in the House of Commons today has acknowledged it is
INTERCURE, which calls itself the ‘most profitable and fastest growing’ cannabis company outside of North America, is poised to open
CONSERVATIVE MPs have blocked efforts to boost UK medical cannabis access with the Government saying the existing legislation is sufficient.
GLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over
A CAMPAIGN group is calling for a review of the way drug driving is tackled and a return to pre-2015
Chartered Psychologist and Head of Research at Drug Science, Dr Anne Katrin Schlag, heads up the newly formed Cannabis Industry
CLAIMS a Canadian cannabis producer misled investors over its purchase of a UK horticultural farm have been dismissed by a
Oxford Cannabinoid Technologies Holdings plc (OCTP), the holding company of Oxford Cannabinoid Technologies Ltd (“OCT”) (together, the “Group”), a company
GUERNSEY cannabis company The House of Green has submitted three of the seven medical cannabis production applications in the UK
THE newly launched Cannabis Industry Council has brought together disparate organisations, working groups and businesses with the aim of driving
THE initial warm welcome to proposals to make UK cannabinoid regulations a matter for the health authorities – not the
We won’t spam you
